BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10932298)

  • 1. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability.
    Ansevin CF
    Neurology; 2000 Aug; 55(3):458-9. PubMed ID: 10932298
    [No Abstract]   [Full Text] [Related]  

  • 2. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability.
    Vernino S; Auger RG; Emslie-Smith AM; Harper CM; Lennon VA
    Neurology; 1999 Oct; 53(6):1233-9. PubMed ID: 10522878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymoma, myasthenia gravis, encephalitis, and a novel anticytoplasmic neuronal antibody.
    Khella SL; Souyah N; Dalmau J
    Neurology; 2007 Sep; 69(12):1302-3. PubMed ID: 17875920
    [No Abstract]   [Full Text] [Related]  

  • 4. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
    Mygland A; Aarli JA; Matre R; Gilhus NE
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.
    Smith CI; Aarli JA; Hammarström L; Persson MA
    Neurology; 1984 Aug; 34(8):1094-6. PubMed ID: 6540388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.
    Mygland A; Tysnes OB; Aarli JA; Matre R; Gilhus NE
    J Autoimmun; 1993 Aug; 6(4):507-15. PubMed ID: 8216692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor dysfunction and autoantibodies in spontaneous thymoma buffalo/Mna rats.
    Iwasa K; Komai K; Asaka T; Nitta E; Takamori M
    Ann N Y Acad Sci; 1998 May; 841():542-5. PubMed ID: 9668291
    [No Abstract]   [Full Text] [Related]  

  • 9. Thymoma-specific antibodies in sera from patients with myasthenia gravis demonstrated by indirect haemagglutination.
    Aarli JA; Lefvert AK; Tönder O
    J Neuroimmunol; 1981 Dec; 1(4):421-7. PubMed ID: 7346525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-titin antibodies are not associated with a specific thymoma histology.
    Voltz R; Albrich W; Hohlfeld R; Nagel D; Wick M; Kirchner T; Sommer N; Illa I; Kaminski H; Schumm F
    J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):282. PubMed ID: 12531976
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis.
    Cuénoud S; Feltkamp TE; Fulpius BW; Oosterhuis HJ
    Neurology; 1980 Feb; 30(2):201-2. PubMed ID: 7188802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis-associated ryanodine receptor antibodies inhibit binding of ryanodine to sarcoplasmic reticulum.
    Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
    Ann N Y Acad Sci; 1998 May; 841():530-3. PubMed ID: 9668288
    [No Abstract]   [Full Text] [Related]  

  • 13. Extractable nuclear antigen autoantibodies and their association with other autoantibodies and thymoma in myasthenia gravis.
    Warlow R; Garlepp M; Dawkins R
    J Neuroimmunol; 1985 May; 8(2-3):185-97. PubMed ID: 3873473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle and neuronal autoantibody markers of thymoma: neurological correlations.
    Vernino S; Lennon VA
    Ann N Y Acad Sci; 2003 Sep; 998():359-61. PubMed ID: 14592897
    [No Abstract]   [Full Text] [Related]  

  • 15. Aquaporin-4 antibody seropositivity in myasthenia gravis patients with thymoma.
    Ekizoğlu E; Yılmaz V; Içöz S; Birişik Ö; Tüzün E; Akman-Demir G; Saruhan-Direskeneli G; Deymeer F
    Muscle Nerve; 2013 Feb; 47(2):306-7. PubMed ID: 23349085
    [No Abstract]   [Full Text] [Related]  

  • 16. Spontaneous neutralising antibodies to interferon--alpha and interleukin-12 in thymoma-associated autoimmune disease.
    Meager A; Vincent A; Newsom-Davis J; Willcox N
    Lancet; 1997 Nov; 350(9091):1596-7. PubMed ID: 9393342
    [No Abstract]   [Full Text] [Related]  

  • 17. The reactivity of the antistriational antibodies associated with thymoma and myasthenia gravis.
    Peers J; McDonald BL; Dawkins RL
    Clin Exp Immunol; 1977 Jan; 27(1):66-73. PubMed ID: 321160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis and thymoma: paraneoplastic failure of neuromuscular transmission.
    Hohlfeld R
    Lab Invest; 1990 Mar; 62(3):241-3. PubMed ID: 2156108
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis.
    Mygland A; Tysnes OB; Matre R; Aarli JA; Gilhus NE
    Autoimmunity; 1994; 17(4):327-31. PubMed ID: 7948615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymoma without myasthenia gravis: electrophysiological study after thymectomy.
    Sanders DB; Howard JF
    J Neurol Neurosurg Psychiatry; 1988 Jan; 51(1):160-1. PubMed ID: 3351526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.